FDA approves first gene therapy treatment for Sanfilippo syndrome type A

The Abigail Wexner Research Institute astatine Nationwide Children's Hospital celebrated the Food and Drug Administration's (FDA) support of FAYUVI for Sanfilippo syndrome benignant A, pursuing years of probe successful its Jerry R. Mendell Center for Gene Therapy to assistance patients with devastating diseases.